GENERAL7 Sept 2026
OncoStem eyes wider access to breast cancer risk test with hospital-use kit
OncoStem now plans to make its breast cancer risk test more accessible with a hospital-use kit. This decentralised model lets hospitals offer the test directly. The company expects its annual testing volume to at least double to around 6,000 from current 3,000. Patients and hospitals gain more access. Ask your hospital or oncologist if they provide this test kit.
Key Statutory Highlights
- OncoStem is looking to increase access to its breast cancer risk test with a hospital-use kit.
- The company expects the decentralised model to at least double annual testing volume to around 6,000 from current 3,000.
- The decentralised model is expected to widen access to the test.
Actionable Advice for Taxpayers / Founders:Ask your hospital or oncologist whether the OncoStem breast cancer risk test is now available using this hospital-use kit.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: